Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated. (2016)
Attributed to:
Design of Trials, Meta-analyses and observational studies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12874-016-0110-x
PubMed Identifier: 26869168
Publication URI: http://europepmc.org/abstract/MED/26869168
Type: Journal Article/Review
Volume: 16
Parent Publication: BMC medical research methodology
ISSN: 1471-2288